E744K (p.Glu744Lys) variant of MFN2 (Mitofusin-2)
E744K (p.Glu744Lys) in MFN2 (Mitofusin-2) is a missense change. Clinical records from ClinVar, EBI, and UniProt describe it as conflicting interpretations in the context of Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; Neuropathy. The available variant effect predictions contribute to a CATVariant prioritization score of 0.77 / 1. The record also includes published literature and structural context.
E744K (p.Glu744Lys) variant details
- p.Glu744Lys
- rs1064794571
- ClinGen CA16616967
- ClinVar RCV000486011
- ClinVar RCV000698484
- Conflicting interpretations
- Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2a2b; Neuropathy
- Missense
- Variant Prioritization Score for Impact Estimate 0.774
- AlphaMissense 0.91
- MetaLR 0.93
- MetaSVM 0.99
- PolyPhen-2 0.91
- SIFT 0.00
- EVE 0.27
- ClinVar: Conflicting classifications of pathogenicity (Charcot-Marie-Tooth disease, axonal, autosomal recessive, type 2)
- EBI: Pathogenic (in CMT2A2A)
- UniProt: Pathogenic (in CMT2A2A)
- Structural context available
- Cited in: Charcot-Marie-Tooth Hereditary Neuropathy Overview. (PMID 20301532)
- Cited in: MFN2 Hereditary Motor and Sensory Neuropathy. (PMID 20301684)